Year-end Sale % OFF 
Abstract
Background: Co-crystals have been highly promising for tailoring physicochemical properties of Active pharmaceutical ingredient (API) by coupling with co-former. Objectives: The objective of the present work was to prepare and characterize novel nano co-crystals of Ezetimibe by different methods in various ratios of co-formers and to optimize the formulation based on the enhancement in solubility and dissolution rate. Methods: Ezetimibe nano co-crystals were prepared employing oxalic acid, succinic acid and maleic acid as co-formers by solvent evaporation method and anti-solvent method. Results: Instrumental analysis of co-crystals (DSC, IR, SEM and XRD) was performed to characterize the novel nano co-crystals. Dissolution studies and chemical stability were assessed and compared with pure Ezetimibe. The formulation with maleic acid as a co-former in the molar ratio of Ezetimibe and maleic acid (0.4:0.4) was found to be efficient than oxalic acid and succinic acid. The co-crystal dissolution profile in distilled water containing 0.5% SLS showed 18.8 folds increase in the dissolution efficiency and was found to be 95.2% within 45 min. Conclusion: The results demonstrate feasibility of co-crystallization method using maleic acid as co-former to enhance the solubility of poorly soluble drug Ezetimibe. Key words: Anti-solvent, Co-Formers, Maleic Acid, Oxalic acid, Solubility, Solvent evaporation, Succinic acid.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
